Beckman Coulter to Distribute IntelliCyt's HyperCyt System | GenomeWeb

NEW YORK (GenomeWeb News) – Beckman Coulter has inked a deal to be exclusive distributor outside of North America for IntelliCyt's HyperCyt system, an automated platform for multiplex cell- and bead-based screening.

Beckman also will hold co-exclusive distribution rights to the system in North America for use on its own CyAn flow cytometer. Beckman said that the combination will "create the fastest available flow cytometric cell analysis system."

Albuquerque, NM-based IntelliCyt will continue to provide direct sales and support of its HyperCyt system in North America.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.